TrialIndian journal of ophthalmology2021

Comparative analysis of safety and efficacy of Alcaftadine 0.25%, Olopatadine hydrochloride 0.2% and Bepotastine besilate 1.5% in allergic conjunctivitis.

Shruti Ayyappanavar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.